Preventing nephropathy induced by contrast medium [19]

New England Journal of Medicine

Volumn 354, Issue 17, 2006, Pages 1853-1854

  Gross, Jorge L ^a   Friedman, Rogerio ^a   Silveiro, Sandra P ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; METFORMIN; BICARBONATE; SODIUM CHLORIDE; ANTIDIABETIC AGENT; ACETYLCYSTEINE;

BODY SURFACE; CREATININE BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; LETTER; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; BLOOD; CHEMICALLY INDUCED DISORDER; NOTE; FEMALE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK;

CONTRAST MEDIA; CREATININE; HUMANS; KIDNEY DISEASES; SODIUM BICARBONATE; SODIUM CHLORIDE; DIABETES MELLITUS, TYPE 2; FEMALE; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; ACETYLCYSTEINE; RISK;

EID: 33646076694     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc060405     Document Type: Letter

References (3)

1. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-86.
2. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-9.
3. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3-9.